Proteapex Therapeutics
In The Media
June 16, 2019
CSO Discusses ECPF-1, a Novel Osteoarthritis Therapeutic
Dr. Marina D’Angelo, CSO, discussed development of ECPF-1, the novel, injectable therapeutic that slows the progression of osteoarthritis.
April 23, 2018
ProteaPex Therapeutics featured in a short film
ProteaPex Therapeutics is presenting several posters at the 2018 Experimental Biology meeting in San Diego, CA. In addition, we are featured in a short film as part of the Thought Leadership Series.
November 14, 2016
ECPF-2, is the subject of a proof-of-concept competition
Our periodontal disease therapeutic, ECPF-2, is the subject of a proof-of-concept competition grant proposal to the University City Science Center. The winners will be announced early 2017.
September 3, 2015
PCOM Faculty Spotlight - Marina D'Angelo PhD
Marina D'Angelo, PhD, CSO and co-founder of ProteaPex Therapeutics, was the recent subject of a Faculty Spotlight.
May 8, 2015
Proteapex Therapeutics featured on Inside Higher Education's Academic Minute
Our lead OA product, ECPF-1, was recently featured on public radio in a segment on pet osteoarthritis.